Update. There is a new conference call available at ChemoCentryx. You can access this for about the next week. Approval for Avacopan is now in the hands of the USFDA. The company is now preparing for marketing and distribution in 2021. In my case I will continue with Rituxin BUT hopefully be able to eliminate the use of the dreaded steroids. This call is about the medical challenges faced by those of us with Anca vasculitis. It is not about their financials. I would like to tell you everything that was said, but it would be best if you listened to it yourself. The speaker cuts off the line three times, but he comes back on, so stay on and he will continue. A lot of information, confirmation of what the steroids are doing to me, and well worth my time.
Be well,